Characterization of mouse carboxypeptidase N small active subunit gene structure

Journal of Immunology

Volumn 166, Issue 10, 2001, Pages 6196-6202

  Matthews, Kirstin W ^a   Wetsel, Rick A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; CARBOXYPEPTIDASE; FIBRINOPEPTIDE; KININ; METALLOPROTEINASE; ZINC;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHROMOSOME; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SUBUNIT; GENE STRUCTURE; IN SITU HYBRIDIZATION; INTRON; MOLECULAR CLONING; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRANSCRIPTION INITIATION;

EID: 0035873437     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.10.6196     Document Type: Article

References (32)

1. Levin, Y., R. A. Skidgel, and E. G. Erdos. 1982. Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase I). Proc. Natl. Acad. Sci. USA 79:4618.
2. Skidgel, R. A. 1996. Structure and function of mammalian zinc carboxypeptidase. In Zinc Metalloprotease in Health and Disease. N. M. Hooper, ed. Taylor and Francis, London, p. 141.
3. Erdos, E. G., and E. M. Sloane. 1962. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11:585.
4. Erdos, E. G. 1979. Bradykinin, kallidin and kallikrein. In Handbook of Experimental Pharmacology. E. G. Erdos, ed. Springer-Verlag, Heidelberg, p. 427.
5. Belew, M., G. B. Lindeberg, J. Porath, T. Saldeen, and R. Wallin. 1980. Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin. Biochim. Biophys. Acta 621:169.
6. Bokisch, V. A., and H. J. Muller-Eberhard. 1970. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49:2427.
7. Ember, J. A., M. A. Jagels, and T. E. Hugli. 1998. Characterization of complement anaphylatoxins and their biological responses. In Human Complement System in Health and Disease. M. Frank and J. Volanakis, eds. Marcel Dekker, New York, p. 241.
8. Wetsel, R. A., J. Kildsgaard, and D. L. Haviland. 2000. Complement anaphylatoxins (C3a, C4a, C5a) and their receptors (C3aR, C5aR/CD88) as therapeutic targets in inflammation. In Therapeutic Interventions in the Complement System. J. D. Lambris and V. M. Holers, eds. Humana Press, Totowa, p. 113.
9. Mathews, K. P. 1986. Deficiencies in regulator proteins 4: anaphylatoxin inactivator. Prog. Allergy 39:344.
10. Mathews, K. P., J. G. Curd, and T. E. Hugli. 1986. Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency. J. Clin. Immunol. 6:87.
11. Gebhard, W., S. Matthias, and M. Eulitz. 1989. cDNA cloning and complete primary structure of the small, active subunit of human carboxypeptidase N. Eur. J. Biochem. 178:603.
12. Tan, F., D. K. Weerasinghe, R. A. Skidgel, H. Tamei, R. K. Kaul, I. B. Roninson, J. W. Schilling, and E. G. Erdos. 1990. The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandem repeats. J. Biol. Chem. 265:13.
13. Riley, D. A., F. Tan, D. J. Miletich, and R. A. Skidgel. 1998. Chromosomal localization of the genes for human carboxypeptidase D (CPD) and the active 50-kilodalton subunit of human carboxypeptidase N (CPN1). Genomics 50:105.
14. Wetsel, R. A., D. T. Fleischer, and D. L. Haviland. 1990. Deficiency of the murine fifth complement component 2-base pair gene deletion in a 5′-exon. J. Biol. Chem. 265:2435.
15. Virca, G. D., W. Northemann, B. R. Shiels, G. Widera, and S. Broome. 1990. Simplified Northern blot hybridization using 5% sodium dodecyl sulfate. BioTechniques 8:370.
16. Lichter, P., C. J. Tang, K. Call, G. Hermanson, G. A. Evans, D. Housman, and D. C. Ward. 1990. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64.
17. Sambrook J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, Ch. 7. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, p. 79.
18. Lewin, B. 1994. Building the transcription complex: promoters, factors, and RNA polymerases. In Genes V. Oxford University Press, Oxford, p. 845.
19. Boffa, M. B., T. S. Reid, E. Joo, M. E. Neshein, and M. L. Koschinsky. 1999. Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). Biochemistry 38:6547.
20. Jung, Y. K., C. J. Kunczt, R. K. Pearson, J. E. Dixon, and L. D. Fricker. 1991. Structural characterization of the rat carboxypeptidase E gene. Mol. Endocrinol. 5:1257.
21. Grange, T., J. Roux, G. Rigaud, and R. Pictet. 1991. Cell-type specific activity of two glucocorticoid responsive units of rat tyrosine aminotransferase gene is associated with multiple binding sites for C/EBP and a novel liver-specific nuclear factor. Nucleic Acids Res. 19:131.
22. Li, L., and W. S. L. Liao. 1999. An upstream repressor element that contributes to hepatocyte-specific expression of the rat serum amyloid A1 gene. Biochem. Biophys. Res. Commun. 264:395.
23. Ren, Y., S. A. G. Reddy, and W. S. L. Liao. 1999. Purification and identification of a tissue-specific repressor involved in serum amyloid A1 gene expression. J. Biol. Chem. 274:37154.
24. Clauser, E., S. J. Gardell, C. S. Craik, R. J. MacDonald, and W. J. Rutter. 1988. Structural characterization of rat carboxypeptidase A1 and B genes. J. Biol. Chem. 263:17837.
25. Gardell, S. J., C. S. Craik, E. Clauser, E. J. Goldsmith, C. B. Stewart, M. Graf, and W. J. Rutter. 1988. A novel rat carboxypeptidase, CPA2: characterization, molecular cloning, and evolutionary implications on substrate specificity in the carboxypeptidase gene family. J. Biol. Chem. 263:17828.
26. Reynolds, D. S., D. S. Gurley, and K. F. Austen. 1992. Cloning and characterization of the novel gene for mast cell carboxypeptidase A. J. Clin. Invest. 89: 273.
27. Sato, T., T. Miwa, H. Akatsu, N. Matsukawa, K. Obata, N. Okada, W. Campbell, and H. Okada. 2000. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not. J. Immunol. 165:1053.
28. Tsai, S. P., and D. Drayna. 1992. The gene encoding human plasma carboxypeptidase B (CPB2) resides on chromosome 13. Genomics 14:549.
29. Honey, N. K., A. Y. Sakaguchi, P. A. Lalley, C. Quinto, W. J. Rutter, and S. L. Naylor. 1986. Assignment of the gene for carboxypeptidase A to human chromosome 7q22-qter and to mouse chromosome 6. Hum. Genet. 72:27.
30. Hall, C., E. Manser, N. K. Spurr, and L. Lim. 1993. Assignment of the human carboxypeptidase E (CPE) gene to chromosome 4. Genomics 15:461.
31. Kas, K., E. F. P. M. Schoenmakers, and W. J. M. Van de Yen. 1995. Physical map location of the human carboxypeptidase M gene (CPM) distal to D12S375 and proximal to D12S8 at chromosome 12q15. Genomics 30:403.
32. Bajzar, L., J. Morser, and M. Nesheim. 1996. TAF1 or plasma procarboxypeptidase B couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271:16603.